Overview

Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress

Status:
Unknown status

Trial end date:
2019-11-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if stopping the stress induced increase in inflammation will prevent sodium retention which in turn increases blood pressure. Each subject will test two separate times. One week, they will be taking a daily dose of mycophenolate mofetil (MMF), the other week they will be taking a placebo.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Augusta University

Treatments:

Immunosuppressive Agents
Mycophenolate mofetil
Mycophenolic Acid